Genome-wide association studies of coronary artery disease and heart failure: where are we going?

Related Experiment Video

Updated: Jun 25, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

Gerald W Dorn1, Sharon Cresci

  • 1Washington University Center for Pharmacogenomics, 660 S. Euclid Avenue, Campus Box 8086, St Louis, MO 63110, USA.

Pharmacogenomics
|February 12, 2009
PubMed

Insights

Genome-wide association studies (GWAS) offer limited insights into the complex genetic causes of heart diseases like coronary artery disease. Further research is needed to understand genetic contributions to these common and serious conditions.

Area of Science:

  • Cardiovascular Genetics
  • Complex Disease Etiology
  • Genomic Medicine

Background:

  • Heart diseases, including coronary artery disease, myocardial infarction, and heart failure, are leading causes of death and disability globally.
  • These conditions are recognized as phenotypically heterogeneous and likely involve complex, polygenic inheritance patterns.
  • The precise genetic contribution to the etiology of these common heart diseases remains incompletely understood.

Purpose of the Study:

  • To review the current application and outcomes of genome-wide association studies (GWAS) in understanding heart diseases.
  • To discuss the limitations encountered in using GWAS for common cardiovascular diseases.
  • To explore future directions for genetic research in coronary artery disease, myocardial infarction, and heart failure.

Main Methods:

  • Review of existing literature on genome-wide association studies (GWAS) applied to cohorts with coronary artery disease, myocardial infarction, and heart failure.
  • Analysis of the successes and limitations of current GWAS methodologies in identifying genetic factors for these conditions.
  • Discussion of potential alternative or complementary approaches for future genetic discovery.

Main Results:

  • Genome-wide association studies (GWAS) have provided limited insights into the genetic underpinnings of common heart diseases to date.
  • Despite technological advancements, the complex polygenic nature of these disorders has hindered clear identification of causative genes through current GWAS approaches.
  • The review highlights the challenges in translating GWAS findings into a comprehensive understanding of disease etiology.

Conclusions:

  • Current genome-wide association studies (GWAS) have not fully elucidated the genetic architecture of major heart diseases.
  • The phenotypic heterogeneity and polygenic nature of coronary artery disease, myocardial infarction, and heart failure present significant challenges for genetic discovery.
  • Future research should explore novel strategies beyond traditional GWAS to identify key genetic factors influencing cardiovascular disease risk and outcomes.

More Related Videos

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...